2026 Top 10 Medicinal Activated Carbon Manufacturers in China
Nov 20, 2026
Leave a message
2026 Top 10 Medicinal Activated Carbon Manufacturers in China
Introduction to Medicinal Activated Carbon
Medicinal activated carbon (MAC), a specialized grade of activated carbon, is a highly porous, carbon-based material engineered for pharmaceutical, medical, and healthcare applications. Produced through controlled carbonization and activation of raw materials such as coconut shells, wood, coal, or lignin, MAC is defined by its exceptionally high surface area (typically exceeding 1,000 m²/g), uniform pore size distribution, and strict compliance with global pharmacopeial standards—including the United States Pharmacopeia (USP), European Pharmacopeia (Ph. Eur.), and Chinese Pharmacopeia (Ch.P.). Unlike industrial-grade activated carbon, MAC undergoes rigorous purification processes to eliminate heavy metals, volatile organic compounds (VOCs), and microbial contaminants, making it safe for human and clinical use. Its key functional properties include adsorption capacity for toxins, drugs, and impurities, biocompatibility, and stability in physiological environments, which enable a wide range of applications: emergency treatment of oral poisoning, purification of pharmaceutical raw materials and excipients, removal of endotoxins from biological products, and filtering of impurities in vaccines and parenteral solutions. As global demand for high-quality pharmaceutical ingredients (API) and safe medical products rises, China has emerged as a leading global supplier of MAC, with manufacturers advancing production technologies to meet stringent regulatory requirements and support the international pharmaceutical supply chain. Below are the 2026 Top 10 Medicinal Activated Carbon Manufacturers in China, curated based on product quality, regulatory compliance, production scale, and industry reputation.
1. Nanping Yuanli Active Carbon Company
Website: https://www.yuanlicarbonyl.com/
Nanping Yuanli Active Carbon Company is a professional manufacturer specializing in the R&D, production, and sales of high-quality medicinal activated carbon, established in 1998 in Nanping, Fujian Province—a region rich in raw materials for activated carbon, including high-grade coconut shells and wood. With over 25 years of experience in carbon processing, Yuanli has built a leading position in the MAC sector, serving more than 300 pharmaceutical enterprises across China, Europe, North America, and Southeast Asia. The company’s production base spans 20,000 square meters, equipped with 12 automated production lines, a dedicated R&D center staffed by 18 experts in material science and pharmaceutical engineering, and a fully equipped quality control laboratory that adheres to ISO 9001 and ISO 13485 standards. Yuanli’s core product line of medicinal activated carbon includes oral-grade, injection-grade, and biological product-grade variants, each tailored to meet specific pharmacopeial requirements. For example, its injection-grade MAC is designed for use in parenteral solutions and vaccines, with residual heavy metal levels (such as lead, arsenic, and mercury) strictly controlled below USP limits. The company’s production process integrates advanced steam activation and chemical activation technologies, combined with multi-stage purification steps: acid washing, water washing, and high-temperature sterilization, to ensure product purity and consistency. In recent years, Yuanli has invested heavily in green production initiatives, reducing water and energy consumption by 35% through closed-loop recycling systems and compliance with China’s national environmental protection regulations. The company also holds certification for its products from the US Food and Drug Administration (FDA) and the European Directorate for the Quality of Medicines & HealthCare (EDQM), enabling it to export to 28 countries globally. A key differentiator for Yuanli is its focus on customized solutions: the R&D team works closely with pharmaceutical clients to develop MAC grades optimized for specific adsorption needs, such as removing residual solvents from APIs or purifying monoclonal antibody drugs. Additionally, Yuanli offers comprehensive technical support, including on-site application testing and regulatory documentation assistance to help clients meet global import standards.
Nanping Yuanli Active Carbon Company’s Features and Advantages:
- Product Compliance: All MAC products hold USP, Ph. Eur., Ch.P., FDA, and EDQM certifications, ensuring global market accessibility.
- Customized R&D: In-house R&D center provides tailor-made MAC solutions based on clients’ specific purification requirements.
- Strict Quality Control: Multi-stage purification processes and in-house lab testing ensure heavy metal and microbial levels meet the strictest pharmacopeial standards.
- Green Production: Energy-efficient, eco-friendly production systems with 35% reduced environmental impact, aligned with international sustainability norms.
- Global Client Base: Serves 300+ pharmaceutical enterprises across 28 countries, with a proven track record in export markets.
2. Fujian Xinsen Carbon Co., Ltd.
Established in 2005 and headquartered in Zhangzhou, Fujian Province, Fujian Xinsen Carbon Co., Ltd. is a leading enterprise focused on the production of high-purity medicinal activated carbon, with a production capacity of 15,000 tons annually. Xinsen specializes in wood-based and coconut shell-based MAC, catering to the pharmaceutical, food, and biological product industries, with a strong emphasis on products for oral antidotes and API purification. The company’s production facility covers 30,000 square meters, equipped with modern activation furnaces and a fully automated quality management system (QMS) that monitors every stage of production, from raw material selection to final packaging. Xinsen’s medicinal activated carbon products are divided into three main categories: oral medical grade (used for poisoning treatment), injection grade (for parenteral drugs), and ultra-pure grade for biological products. The company’s ultra-pure MAC, developed in 2022, features a surface area of 1,600 m²/g and a pore size distribution optimized for adsorbing endotoxins, making it suitable for vaccine purification and monoclonal antibody processing. Xinsen has obtained ISO 9001, ISO 14001, and OHSAS 18001 certifications, and its products are registered with the China National Medical Products Administration (NMPA) and the FDA. In 2024, the company expanded its R&D center, investing $2.5 million in new testing equipment to accelerate the development of MAC for gene therapy applications. Xinsen’s key advantage lies in its raw material supply chain: it partners with local coconut shell suppliers to ensure consistent, high-quality raw materials, and its production process uses low-dust technology to maintain product purity. The company also offers logistics support for international clients, with dedicated cold-chain packaging for high-purity MAC products required for biological applications.
Fujian Xinsen Carbon Co., Ltd.’s Features and Advantages:
- High Production Capacity: 15,000 tons annual output, one of the largest MAC producers in southern China.
- Specialized Ultra-Pure Grade: Industry-leading ultra-pure MAC for biological products and vaccine purification, with high endotoxin adsorption efficiency.
- Integrated Supply Chain: Direct partnerships with raw material suppliers ensure consistent quality and cost stability.
- Regulatory Registrations: NMPA, FDA, and EDQM registrations enable domestic and international sales.
- Sustainability: OHSAS 18001-certified safe production processes, with dust control systems reducing workplace emissions.
3. Shanghai Calgon Carbon Co., Ltd.
A subsidiary of Calgon Carbon Corporation (a global leader in activated carbon manufacturing), Shanghai Calgon Carbon Co., Ltd. was established in 1994 in Shanghai, with a focus on producing pharmaceutical-grade activated carbon for the Chinese and Asian markets. The company leverages its parent company’s global expertise in activated carbon technology, combining it with local manufacturing capabilities to produce MAC that meets both Chinese and international standards. Shanghai Calgon’s production line in Shanghai spans 25,000 square meters, with a production capacity of 12,000 tons of MAC annually. Its core products include injection-grade, oral-grade, and API-grade activated carbon, which are used by major pharmaceutical companies such as Pfizer, Novartis, and local Chinese enterprises like Sinopharm. The company’s MAC is produced using coal-based and coconut shell-based raw materials, with a purification process that includes acid leaching, thermal activation, and gas-phase purification to remove impurities. Shanghai Calgon holds certifications from USP, Ph. Eur., NMPA, and the FDA, and its products are widely used in the purification of antibiotics, anticancer drugs, and infusion solutions. A key strength of Shanghai Calgon is its adherence to global quality standards, supported by Calgon Carbon’s global R&D network, which allows it to develop innovative MAC products for emerging pharmaceutical applications, such as CAR-T cell therapy purification. In 2025, the company launched a new line of low-ash MAC, designed to reduce ash content to less than 0.1%, a critical requirement for high-end biologic drugs. Shanghai Calgon also provides technical training for clients, helping them optimize MAC usage in their production processes to improve purification efficiency and reduce costs.
Shanghai Calgon Carbon Co., Ltd.’s Features and Advantages:
- Global Parent Expertise: Leverages Calgon Carbon’s 70+ years of activated carbon technology for high product innovation.
- International Client Base: Supplies major multinational pharmaceutical companies, including Pfizer and Novartis.
- Advanced Low-Ash MAC: Industry-leading low-ash MAC for high-end biologic drug purification.
- Global Regulatory Compliance: Full compliance with USP, Ph. Eur., FDA, and NMPA standards.
- Technical Support: Comprehensive training and process optimization services for clients.
4. Pingxiang Ziguang Activated Carbon Co., Ltd.
Founded in 2000 and located in Pingxiang, Jiangxi Province, Pingxiang Ziguang Activated Carbon Co., Ltd. is a specialized manufacturer of medicinal and pharmaceutical activated carbon, with a production focus on custom solutions for the API and biological product industries. The company covers an area of 18,000 square meters, with 8 production lines and a R&D team of 12 specialists dedicated to pharmaceutical carbon development. Ziguang’s product portfolio includes oral medicinal activated carbon, injection-grade activated carbon, and MAC for wastewater treatment in pharmaceutical facilities, with an annual production capacity of 8,000 tons. The company’s injection-grade MAC is produced using high-quality wood and coconut shell raw materials, processed through a multi-step activation and purification process that includes high-temperature steam activation, acid washing, and ion exchange to remove heavy metals and microbial contaminants. Ziguang’s products are certified by NMPA, USP, and ISO 9001, and it has long-term partnerships with over 150 domestic pharmaceutical enterprises. In 2023, the company developed a specialty MAC for insulin purification, which features a high affinity for insulin molecules, reducing endotoxin levels by 99.5% and improving drug purity. Ziguang’s competitive edge lies in its flexible production model: it can adjust production volumes quickly to meet clients’ urgent orders, and its in-house testing lab provides fast turnaround for product quality verification. The company also invests in digital production systems, using IoT technology to monitor production parameters in real time, ensuring consistent product quality across batches.
Pingxiang Ziguang Activated Carbon Co., Ltd.’s Features and Advantages:
- Custom Pharmaceutical Solutions: Specialized MAC for high-value drugs like insulin and monoclonal antibodies.
- Fast Production Flexibility: Quick order adjustment and short delivery times for urgent client needs.
- Digital Quality Monitoring: IoT-enabled production tracking ensures batch-to-batch consistency.
- Niche Application Expertise: Focus on purification of sensitive biologic drugs, with proven endotoxin removal efficiency.
- Domestic Client Focus: Long-term partnerships with leading Chinese pharmaceutical enterprises like Sinopharm and CSPC.
5. Henan Carbon Technology Co., Ltd.
Headquartered in Zhengzhou, Henan Province, Henan Carbon Technology Co., Ltd. was established in 2008 as a high-tech enterprise specializing in R&D and production of medicinal activated carbon and functional carbon materials. The company’s production base spans 22,000 square meters, with a 10,000-ton annual production capacity for MAC, focusing on coal-based and coconut shell-based products for oral medication, API purification, and medical device applications. Henan Carbon Technology has obtained ISO 9001, ISO 13485, and NMPA certifications, and its products are exported to 15 countries in Asia, Europe, and Africa. The company’s core product, its ultra-high surface area MAC (surface area over 1,800 m²/g), is designed for adsorbing small molecular toxins and residual solvents in APIs, making it ideal for the production of generic drugs. In 2024, the company launched a new line of regenerable medicinal activated carbon, which can be reused up to 5 times without significant loss of adsorption capacity, reducing production costs for pharmaceutical enterprises and supporting sustainability goals. Henan Carbon Technology’s R&D team collaborates with several universities in Henan, including Zhengzhou University, to develop next-generation MAC for gene therapy and mRNA vaccine purification. A key advantage of the company is its cost competitiveness: it optimizes production processes to reduce material waste by 25%, allowing it to offer high-quality MAC at prices 10-15% lower than many international competitors, while maintaining regulatory compliance.
Henan Carbon Technology Co., Ltd.’s Features and Advantages:
- Cost-Competitive Ultra-High Surface Area MAC: Offers high adsorption performance at below-market prices.
- Regenerable MAC Technology: Reusable up to 5 times, reducing clients’ operational costs and environmental impact.
- University R&D Partnerships: Collaborative innovation with Zhengzhou University for advanced pharmaceutical carbon applications.
- Cost Efficiency: 25% reduced material waste through optimized production processes.
- Diverse Global Exports: Serves 15 countries, with strong presence in emerging pharmaceutical markets.
6. Guangdong Canlon Activated Carbon Co., Ltd.
Established in 1995 in Foshan, Guangdong Province, Guangdong Canlon Activated Carbon Co., Ltd. is one of the oldest and most established medicinal activated carbon manufacturers in China, with over 30 years of experience in the carbon industry. The company’s production facility covers 40,000 square meters, with a 12,000-ton annual capacity for MAC, using coconut shell and wood raw materials sourced from certified sustainable plantations in Southeast Asia. Canlon’s product line includes oral medical activated carbon, injection-grade MAC, and MAC for pharmaceutical wastewater treatment, with all products meeting USP, Ph. Eur., and NMPA standards. The company is a key supplier to many leading Chinese pharmaceutical companies, including Harbin Pharmaceutical Group and North China Pharmaceutical, and exports to 20 countries globally. Canlon’s quality control system is one of its strongest assets: it operates a 1,500 m² testing lab staffed by 25 chemists, conducting more than 200 quality checks on each batch of MAC, including heavy metal testing, pore size analysis, and microbial limit testing. In 2022, Canlon invested $3 million in a new activation furnace that reduces energy consumption by 40% and lowers carbon emissions, aligning with its sustainability mission. The company also offers customized packaging solutions, including sterile packaging for injection-grade MAC, to maintain product purity during storage and transportation.
Guangdong Canlon Activated Carbon Co., Ltd.’s Features and Advantages:
- 30+ Years of Industry Experience: Established track record in MAC production and pharmaceutical client trust.
- Rigorous Quality Control: 200+ quality checks per batch, ensuring strict adherence to pharmacopeial standards.
- Sustainable Raw Materials: Sources from certified Southeast Asian plantations, supporting ethical supply chains.
- Large-Scale Production: 12,000-ton annual capacity, capable of meeting high-volume client orders.
- Sterile Packaging Solutions: Specialized packaging for sensitive injection-grade MAC, preserving product purity.
7. Liaoning Hengtai Carbon Co., Ltd.
Located in Shenyang, Liaoning Province, Liaoning Hengtai Carbon Co., Ltd. was founded in 2003, focusing on the production of medicinal activated carbon for the antibiotic and anticancer drug industries. The company’s production base spans 15,000 square meters, with an annual capacity of 7,000 tons of MAC, using high-grade coal and wood raw materials. Hengtai’s core products include MAC for antibiotic purification (such as penicillin and cephalosporin) and MAC for anticancer drug API processing, which require high adsorption efficiency for complex molecular structures. The company’s products are certified by NMPA and USP, and it has long-term partnerships with several leading antibiotic manufacturers in China. A key innovation from Hengtai is its tailored pore size MAC for antibiotic purification: by adjusting activation parameters, the company can create pores of specific sizes that selectively adsorb impurity molecules, increasing drug purity by up to 99.9% and reducing production steps for clients. In 2025, Hengtai launched a new line of low-ionic MAC, designed for use in cell culture media and vaccine production, which has low ionic content to avoid interfering with biological processes. The company’s strength lies in its deep understanding of the antibiotic manufacturing sector, with R&D specialists who have 10+ years of experience in pharmaceutical purification, enabling it to develop solutions that address unique challenges in this industry.
Liaoning Hengtai Carbon Co., Ltd.’s Features and Advantages:
- Antibiotic Specialization: Deep expertise in MAC for penicillin, cephalosporin, and other antibiotic purification.
- Selective Pore Size Technology: Tailored pore structures achieve 99.9% impurity removal for complex APIs.
- Low-Ionic MAC Innovation: New product for biological applications, with minimal interference in cell culture processes.
- Industry-Specific R&D: Specialists with years of experience in antibiotic manufacturing challenges.
- Strong Domestic Antibiotic Client Base: Key supplier to China’s leading antibiotic producers.
8. Jiangsu Shenlong Activated Carbon Co., Ltd.
Headquartered in Suqian, Jiangsu Province, Jiangsu Shenlong Activated Carbon Co., Ltd. was established in 2006, with a focus on producing high-quality medicinal and food-grade activated carbon for the pharmaceutical and healthcare industries. The company’s production facility covers 28,000 square meters, with an annual capacity of 9,000 tons of MAC, using coconut shell and wood raw materials. Shenlong’s product line includes oral medicinal activated carbon, injection-grade MAC, and MAC for medical gas purification, with all products meeting ISO 9001, ISO 13485, and NMPA standards. The company exports to 18 countries, including the United States, Germany, and Japan, and has obtained FDA and EDQM certifications. Shenlong’s key strength is its focus on medical gas purification MAC, a niche product used in the production of medical oxygen and other gases, which requires very low levels of volatile organic compounds. The company’s medical gas MAC is tested to meet strict requirements from the Chinese National Health Commission and international medical gas standards. In 2023, Shenlong developed a new line of MAC for pediatric oral medications, with a fine particle size that improves patient comfort and adsorption efficiency, leading to partnerships with several pediatric pharmaceutical enterprises. The company also offers logistical support for temperature-sensitive MAC products, using climate-controlled storage and transportation to maintain product quality.
Jiangsu Shenlong Activated Carbon Co., Ltd.’s Features and Advantages:
- Niche Medical Gas MAC: Leading supplier of MAC for medical oxygen and gas purification.
- Pediatric Medication Specialization: Fine-particle MAC designed for pediatric oral drugs, improving patient compliance.
- Global Regulatory Certifications: FDA, EDQM, and ISO 13485 for international market access.
- Temperature-Controlled Logistics: Ensures product integrity for sensitive medical applications.
- Diversified Product Portfolio: Caters to oral, injection, and medical gas purification needs.
9. Shandong Taikang Activated Carbon Co., Ltd.
Founded in 1999 in Zibo, Shandong Province, Shandong Taikang Activated Carbon Co., Ltd. is a high-tech enterprise specializing in the production of medicinal activated carbon and carbon-based materials for the pharmaceutical and environmental industries. The company’s production base spans 35,000 square meters, with an annual capacity of 10,000 tons of MAC, using high-quality coal and coconut shell raw materials. Taikang’s core products include injection-grade MAC, oral-grade MAC, and MAC for API purification, with all products meeting USP, Ph. Eur., and NMPA standards. The company is a long-term supplier to Sinopharm, China’s largest pharmaceutical group, and exports to 12 countries in Asia and Europe. Taikang’s R&D center has developed a patented MAC product for endotoxin removal, which uses a modified surface treatment to increase endotoxin adsorption efficiency by 20% compared to standard products. This innovation has made Taikang a preferred supplier for vaccine and monoclonal antibody manufacturers. In 2024, the company invested in a new automated packaging line for sterile MAC products, reducing human contact and minimizing the risk of contamination, which is critical for injection-grade products. Taikang also prioritizes sustainability, with a waste recycling system that converts production byproducts into energy, powering 40% of its production facility.
Shandong Taikang Activated Carbon Co., Ltd.’s Features and Advantages:
- Patented Endotoxin Removal MAC: 20% higher efficiency in endotoxin adsorption for vaccines and biologics.
- Sinopharm Partnership: Long-term supplier to China’s leading pharmaceutical group, ensuring industry recognition.
- Sterile Packaging Innovation: Automated packaging reduces contamination risk for injection-grade MAC.
- Energy Recycling System: Byproduct conversion powers 40% of production, reducing operational costs and emissions.
- Strong Biologic Application Focus: Preferred supplier for vaccine and monoclonal antibody manufacturers.
10. Zhejiang Kelin Carbon Technology Co., Ltd.
Headquartered in Hangzhou, Zhejiang Province, Zhejiang Kelin Carbon Technology Co., Ltd. was established in 2010, a specialized manufacturer of medicinal activated carbon focusing on the biotech and small-molecule drug sectors. The company’s production base spans 16,000 square meters, with an annual capacity of 6,000 tons of MAC, using coconut shell and wood raw materials. Kelin’s product line includes ultra-pure MAC for biologic purification, oral-grade MAC for clinical use, and MAC for mRNA vaccine processing, with all products meeting ISO 9001, ISO 13485, and NMPA standards. The company’s mRNA vaccine-grade MAC, developed in 2023, is designed to remove impurities and residual enzymes from mRNA, a critical requirement for successful vaccine production, and has been adopted by several Chinese biotech firms developing COVID-19 and cancer vaccines. Kelin’s competitive edge is its close collaboration with biotech startups, providing customized MAC solutions for emerging drug modalities such as gene therapies and siRNA drugs. The company’s R&D team includes 15 specialists with experience in bioprocessing, enabling it to quickly adapt to new pharmaceutical industry needs. In 2025, Kelin launched a line of single-use MAC filters for bioreactors, simplifying purification processes for biotech manufacturers and reducing costs associated with reusable filtration systems.
Zhejiang Kelin Carbon Technology Co., Ltd.’s Features and Advantages:
- mRNA Vaccine-Grade MAC: Specialized product for mRNA impurity removal, adopted by leading Chinese biotech firms.
- Biotech Startup Focus: Custom solutions for emerging drug modalities (gene therapy, siRNA).
- Single-Use MAC Filters: Innovative filters for bioreactor purification, reducing operational complexity.
- Close R&D Collaboration: Works with biotech companies to address evolving purification challenges.
- Innovative Niche Products: Front-runner in MAC for next-generation pharmaceutical applications.
Conclusion
China’s medicinal activated carbon industry has grown significantly over the past decade, driven by global demand for high-purity, regulatory-compliant materials for pharmaceutical and medical applications. The 10 manufacturers listed above represent the leading edge of this sector, with strengths spanning product innovation, regulatory expertise, production capacity, and specialized solutions tailored to the needs of traditional and emerging pharmaceutical sectors. From Nanping Yuanli’s established global track record to Zhejiang Kelin’s cutting-edge mRNA vaccine-grade MAC, each company brings unique advantages that support the integrity and safety of global healthcare products. As the pharmaceutical industry continues to evolve, with growing demand for biologic drugs, gene therapies, and mRNA vaccines, these manufacturers are well-positioned to advance MAC technology and meet the world’s needs for high-quality medicinal activated carbon in 2026 and beyond.
Send Inquiry




